#$%^&*AU2018260937A120181206.pdf#####Abstract: Compositions comprising compounds, or pharmaceutically acceptable salts, that metabolize to monomethyl fumarate (MMF), such as dimethyl fumarate (DMF), and methods for treating, prophylaxis, or amelioration of neurodegenerative diseases including multiple sclerosis using such compositions in a subject.